|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
Cellular and Molecular Physiology Laboratory (CMPL), Department of Obstetrics and Gynaecology, Medical Research Centre (CIM), School of Medicine, Pontificia Universidad Católica de Chile, PO Box 114-D, Santiago, Chile
2
Program of Pathophysiology, ICBM, Faculty of Medicine, Universidad de Chile, PO Box 16038, Santiago, Chile
Gestational diabetes is associated with increased L-arginine transport and nitric oxide (NO) synthesis, and reduced adenosine transport in human umbilical vein endothelial cells (HUVEC). Adenosine increases endothelial L-arginine/NO pathway via A2 purinoceptors in HUVEC from normal pregnancies. It is unknown whether the effect of gestational diabetes is associated with activation of these purinoceptors or altered expression of human cationic amino acid transporter 1 (hCAT-1) or human equilibrative nucleoside transporter 1 (hENT1), or endothelial NO synthase (eNOS) in HUVEC. Cells were isolated from normal or gestational diabetic pregnancies and cultured up to passage 2. Gestational diabetes increased hCAT-1 mRNA expression (2.4-fold) and activity, eNOS mRNA (2.3-fold), protein level (2.1-fold), and phosphorylation (3.8-fold), but reduced hENT1 mRNA expression (32%) and activity. Gestational diabetes increased extracellular adenosine (2.7 µM), and intracellular L-arginine (1.9 mM) and L-citrulline (0.7 mM) levels compared with normal cells (0.05 µM, 0.89 mM, 0.35 mM, respectively). Incubation of HUVEC from normal pregnancies with 1 µM nitrobenzylthioinosine (NBMPR) mimicked the effect of gestational diabetes, but NBMPR was ineffective in diabetic cells. Gestational diabetes and NBMPR effects involved eNOS, PKC and p42/44mapk activation, and were blocked by the A2a purinoceptor antagonist ZM-241385. Thus, gestational diabetes increases the L-arginine/NO pathway involving activation of mitogen-activated protein (MAP) kinases, protein kinase C (PKC) and NO cell signalling cascades following activation of A2a purinoceptors by extracellular adenosine. A functional relationship is proposed between adenosine transport and modulation of L-arginine transport and NO synthesis in HUVEC, which could be determinant in regulating vascular reactivity in diabetes mellitus.
(Received 17 May 2004;
accepted after revision 21 July 2004;
first published online 22 July 2004)
Corresponding author L. Sobrevia: Cellular & Molecular Physiology Laboratory (CMPL), Department of Obstetrics and Gynaecology, Medical Research Centre (CIM), School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, PO Box 114-D, Santiago, Chile. Email: sobrevia{at}med.puc.cl
This article has been cited by other articles:
![]() |
N. Nassar and A. A. Abdel-Rahman Brainstem Phosphorylated Extracellular Signal-Regulated Kinase 1/2-Nitric-Oxide Synthase Signaling Mediates the Adenosine A2A-Dependent Hypotensive Action of Clonidine in Conscious Aortic Barodenervated Rats J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 79 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Omori, H. Fukata, K. Sato, K. Yamazaki, K. Aida-Yasuoka, H. Takigami, M. Kuriyama, M. Ichinose, and C. Mori Polychlorinated biphenyls alter the expression of endothelial nitric oxide synthase mRNA in human umbilical vein endothelial cells Human and Experimental Toxicology, October 1, 2007; 26(10): 811 - 816. [Abstract] [PDF] |
||||
![]() |
P. Casanello, A. Torres, F. Sanhueza, M. Gonzalez, M. Farias, V. Gallardo, M. Pastor-Anglada, R. S. Martin, and L. Sobrevia Equilibrative Nucleoside Transporter 1 Expression Is Downregulated by Hypoxia in Human Umbilical Vein Endothelium Circ. Res., July 8, 2005; 97(1): 16 - 24. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |